News
EMCDDA releases third trendspotter study on COVID-19 and drugs
In the third in its series of rapid ‘trendspotter’ studies, the EMCDDA explores the impact of COVID-19 on the drug situation and responses to it. Revisiting and reviewing findings from two studies...